ID   TN5P_ECOLX              Reviewed;         476 AA.
AC   Q46731; Q08JA5; Q47661; Q57460;
DT   14-OCT-2008, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   01-APR-2015, entry version 74.
DE   RecName: Full=Transposase for transposon Tn5;
DE            EC=3.1.-.-;
DE   AltName: Full=Tnp;
GN   Name=tnpA; Synonyms=tnp;
OS   Escherichia coli.
OG   Plasmid pO86A1.
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacteriales;
OC   Enterobacteriaceae; Escherichia.
OX   NCBI_TaxID=562;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORMS 1 AND 2), AND FUNCTION.
RX   PubMed=6260374; DOI=10.1016/0092-8674(81)90284-1;
RA   Rothstein S.J., Reznikoff W.S.;
RT   "The functional differences in the inverted repeats of Tn5 are caused
RT   by a single base pair nonhomology.";
RL   Cell 23:191-199(1981).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORMS 1 AND 2).
RX   PubMed=6271452;
RA   Auerswald E.A., Ludwig G., Schaller H.;
RT   "Structural analysis of Tn5.";
RL   Cold Spring Harb. Symp. Quant. Biol. 45:107-113(1981).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1).
RX   PubMed=7867940; DOI=10.1016/0378-1119(94)00854-L;
RA   Ahmed A., Podemski L.;
RT   "The revised nucleotide sequence of Tn5.";
RL   Gene 154:129-130(1995).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1).
RC   STRAIN=DIJ1; PLASMID=pO86A1;
RA   Yamamoto T.;
RT   "pO86A1 is a Tn5-insert derivative of adherence plasmid pO86A in
RT   strain DIJ1.";
RL   Submitted (MAR-2006) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   PROTEIN SEQUENCE OF N-TERMINUS, AND ALTERNATIVE PROMOTER USAGE.
RX   PubMed=2438419; DOI=10.1016/0022-2836(86)90028-8;
RA   Krebs M.P., Reznikoff W.S.;
RT   "Transcriptional and translational initiation sites of IS50. Control
RT   of transposase and inhibitor expression.";
RL   J. Mol. Biol. 192:781-791(1986).
RN   [6]
RP   FUNCTION.
RX   PubMed=6291786; DOI=10.1016/0092-8674(82)90292-6;
RA   Johnson R.C., Yin J.C.P., Reznikoff W.S.;
RT   "Control of Tn5 transposition in Escherichia coli is mediated by
RT   protein from the right repeat.";
RL   Cell 30:873-882(1982).
RN   [7]
RP   FUNCTION.
RX   PubMed=6303899;
RA   Lowe J.B., Berg D.E.;
RT   "A product of the Tn5 transposase gene inhibits transposition.";
RL   Genetics 103:605-615(1983).
RN   [8]
RP   FUNCTION, AND MUTAGENESIS OF MET-56; GLU-110 AND GLU-345.
RX   PubMed=1310499;
RA   Wiegand T.W., Reznikoff W.S.;
RT   "Characterization of two hypertransposing Tn5 mutants.";
RL   J. Bacteriol. 174:1229-1239(1992).
RN   [9]
RP   FUNCTION, AND SUBUNIT.
RX   PubMed=8226636;
RA   de la Cruz N.B., Weinreich M.D., Wiegand T.W., Krebs M.P.,
RA   Reznikoff W.S.;
RT   "Characterization of the Tn5 transposase and inhibitor proteins: a
RT   model for the inhibition of transposition.";
RL   J. Bacteriol. 175:6932-6938(1993).
RN   [10]
RP   FUNCTION, AND SUBUNIT.
RX   PubMed=8871560; DOI=10.1093/nar/24.19.3790;
RA   York D., Reznikoff W.S.;
RT   "Purification and biochemical analyses of a monomeric form of Tn5
RT   transposase.";
RL   Nucleic Acids Res. 24:3790-3796(1996).
RN   [11]
RP   MUTAGENESIS OF TYR-41; THR-47 AND GLU-54.
RX   PubMed=9268665; DOI=10.1006/jmbi.1997.1188;
RA   Zhou M., Reznikoff W.S.;
RT   "Tn5 transposase mutants that alter DNA binding specificity.";
RL   J. Mol. Biol. 271:362-373(1997).
RN   [12]
RP   MUTAGENESIS OF ARG-30; LYS-40 AND ARG-62.
RX   PubMed=11283001; DOI=10.1074/jbc.M010748200;
RA   Twining S.S., Goryshin I.Y., Bhasin A., Reznikoff W.S.;
RT   "Functional characterization of arginine 30, lysine 40, and arginine
RT   62 in Tn5 transposase.";
RL   J. Biol. Chem. 276:23135-23143(2001).
RN   [13]
RP   FUNCTION, AND MUTAGENESIS OF ASP-97; ASP-188; TYR-319; ARG-322;
RP   GLU-326; LYS-330 AND LYS-333.
RX   PubMed=11877443; DOI=10.1074/jbc.M200742200;
RA   Naumann T.A., Reznikoff W.S.;
RT   "Tn5 transposase active site mutants.";
RL   J. Biol. Chem. 277:17623-17629(2002).
RN   [14]
RP   MUTAGENESIS OF ARG-342; GLU-344; ASN-348; SER-438; LYS-439 AND
RP   SER-445.
RX   PubMed=17693501; DOI=10.1128/JB.00524-07;
RA   Vaezeslami S., Sterling R., Reznikoff W.S.;
RT   "Site-directed mutagenesis studies of Tn5 transposase residues
RT   involved in synaptic complex formation.";
RL   J. Bacteriol. 189:7436-7441(2007).
RN   [15]
RP   REVIEW.
RX   PubMed=18680433; DOI=10.1146/annurev.genet.42.110807.091656;
RA   Reznikoff W.S.;
RT   "Transposon tn5.";
RL   Annu. Rev. Genet. 42:269-286(2008).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (2.9 ANGSTROMS) OF 56-476.
RX   PubMed=10207011; DOI=10.1074/jbc.274.17.11904;
RA   Davies D.R., Mahnke Braam L., Reznikoff W.S., Rayment I.;
RT   "The three-dimensional structure of a Tn5 transposase-related protein
RT   determined to 2.9-A resolution.";
RL   J. Biol. Chem. 274:11904-11913(1999).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF MUTANT LYS-54/ALA-56/PRO-372
RP   IN COMPLEX WITH DNA AND MANGANESE IONS, COFACTOR, AND SUBUNIT.
RX   PubMed=10884228; DOI=10.1126/science.289.5476.77;
RA   Davies D.R., Goryshin I.Y., Reznikoff W.S., Rayment I.;
RT   "Three-dimensional structure of the Tn5 synaptic complex transposition
RT   intermediate.";
RL   Science 289:77-85(2000).
RN   [18]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF MUTANT
RP   LYS-54/ALA-56/LYS-345/PRO-372 IN COMPLEX WITH DNA AND MANGANESE IONS,
RP   AND FUNCTION.
RX   PubMed=12367522; DOI=10.1016/S0022-2836(02)00877-X;
RA   Steiniger-White M., Bhasin A., Lovell S., Rayment I., Reznikoff W.S.;
RT   "Evidence for 'unseen' transposase-DNA contacts.";
RL   J. Mol. Biol. 322:971-982(2002).
RN   [19]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF MUTANT
RP   LYS-54/ALA-56/LYS-119/ALA-120/LYS-345/PRO-372 IN COMPLEX WITH
RP   MANGANESE IONS AND DNA, COFACTOR, AND SUBUNIT.
RX   PubMed=11896402; DOI=10.1038/nsb778;
RA   Lovell S., Goryshin I.Y., Reznikoff W.R., Rayment I.;
RT   "Two-metal active site binding of a Tn5 transposase synaptic
RT   complex.";
RL   Nat. Struct. Biol. 9:278-281(2002).
RN   [20]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF MUTANT
RP   LYS-54/ALA-56/LYS-119/ALA-120/LYS-345/PRO-372 IN COMPLEX WITH DNA AND
RP   MANGANESE IONS, SUBUNIT, AND COFACTOR.
RX   PubMed=15102449; DOI=10.1016/j.sbi.2004.01.008;
RA   Steiniger-White M., Rayment I., Reznikoff W.S.;
RT   "Structure/function insights into Tn5 transposition.";
RL   Curr. Opin. Struct. Biol. 14:50-57(2004).
CC   -!- FUNCTION: Mediates transposition of transposon Tn5 by a 'cut and
CC       paste' mechanism. First, the monomeric transposase binds the 19 bp
CC       inverted DNA repeats flanking the transposon. Then, dimerization
CC       of the DNA-bound transposase creates a synaptic DNA complex. After
CC       nicking of the first DNA strand, excision of the transposon
CC       proceeds through a series of intermediates. The transposase then
CC       mediates the insertion of the transposon at a new site by strand
CC       transfer. The activity of the wild-type transposase is very low,
CC       and is further inhibited by dimerization with the transposase
CC       inhibitor (inh). {ECO:0000269|PubMed:11877443,
CC       ECO:0000269|PubMed:12367522, ECO:0000269|PubMed:1310499,
CC       ECO:0000269|PubMed:6260374, ECO:0000269|PubMed:6291786,
CC       ECO:0000269|PubMed:6303899, ECO:0000269|PubMed:8226636,
CC       ECO:0000269|PubMed:8871560}.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000269|PubMed:10884228,
CC         ECO:0000269|PubMed:11896402, ECO:0000269|PubMed:15102449};
CC       Note=Binds 2 magnesium ions per subunit.
CC       {ECO:0000269|PubMed:10884228, ECO:0000269|PubMed:11896402,
CC       ECO:0000269|PubMed:15102449};
CC   -!- SUBUNIT: Monomer. Homodimer of tnp (isoform 1), and heterodimer of
CC       tnp (isoform 1) and inh (isoform 2). {ECO:0000269|PubMed:10884228,
CC       ECO:0000269|PubMed:11896402, ECO:0000269|PubMed:12367522,
CC       ECO:0000269|PubMed:15102449, ECO:0000269|PubMed:8226636,
CC       ECO:0000269|PubMed:8871560}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative promoter usage; Named isoforms=2;
CC       Name=1; Synonyms=Transposase, Tnp;
CC         IsoId=Q46731-1; Sequence=Displayed;
CC       Name=2; Synonyms=Transposition inhibitor, Inh;
CC         IsoId=Q46731-2; Sequence=VSP_035522;
CC         Note=Expressed at 4 times higher levels than isoform 1.;
CC   -!- MISCELLANEOUS: Tn5 is a bacterial transposon that contains three
CC       genes conferring resistance to the antibiotics kanamycin/neomycin,
CC       bleomycin and streptomycin, flanked by two IS50 elements. IS50R
CC       codes for the functional transposase (isoform 1) and for the
CC       transposition inhibitor (isoform 2). IS50L differs by one
CC       nucleotide, giving rise to an ochre stop codon and producing C-
CC       terminally truncated proteins that lack transposase activity.
CC   -!- SIMILARITY: Belongs to the transposase 11 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAF34032.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U00004; AAA73393.1; -; Genomic_DNA.
DR   EMBL; U00004; AAA73394.1; -; Genomic_DNA.
DR   EMBL; V00617; CAA23891.1; -; Genomic_DNA.
DR   EMBL; U15573; AAB60064.1; -; Genomic_DNA.
DR   EMBL; AB255435; BAF34032.1; ALT_INIT; Genomic_DNA.
DR   RefSeq; YP_788129.1; NC_008460.1.
DR   PDB; 1B7E; X-ray; 2.90 A; A=56-476.
DR   PDB; 1MM8; X-ray; 2.80 A; A=1-476.
DR   PDB; 1MUH; X-ray; 2.30 A; A=1-476.
DR   PDB; 1MUS; X-ray; 1.90 A; A=1-476.
DR   PDB; 3ECP; X-ray; 2.50 A; A=1-476.
DR   PDB; 4DM0; X-ray; 2.50 A; A=1-476.
DR   PDBsum; 1B7E; -.
DR   PDBsum; 1MM8; -.
DR   PDBsum; 1MUH; -.
DR   PDBsum; 1MUS; -.
DR   PDBsum; 3ECP; -.
DR   PDBsum; 4DM0; -.
DR   ProteinModelPortal; Q46731; -.
DR   SMR; Q46731; 5-476.
DR   DIP; DIP-17010N; -.
DR   GeneID; 4364164; -.
DR   KEGG; pg:4364164; -.
DR   EvolutionaryTrace; Q46731; -.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0004519; F:endonuclease activity; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004803; F:transposase activity; IEA:InterPro.
DR   GO; GO:0006313; P:transposition, DNA-mediated; IEA:InterPro.
DR   Gene3D; 1.10.246.40; -; 1.
DR   Gene3D; 1.10.740.10; -; 1.
DR   Gene3D; 3.90.350.10; -; 1.
DR   InterPro; IPR012337; RNaseH-like_dom.
DR   InterPro; IPR002559; Transposase_11.
DR   InterPro; IPR003201; Transposase_Tn5.
DR   InterPro; IPR014737; Transposase_Tn5-like_C.
DR   InterPro; IPR014736; Transposase_Tn5-like_core.
DR   InterPro; IPR014735; Transposase_Tn5-like_N.
DR   Pfam; PF01609; DDE_Tnp_1; 1.
DR   Pfam; PF02281; Dimer_Tnp_Tn5; 1.
DR   Pfam; PF14706; Tnp_DNA_bind; 1.
DR   SUPFAM; SSF53098; SSF53098; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative promoter usage; Direct protein sequencing;
KW   DNA recombination; DNA-binding; Endonuclease; Hydrolase; Magnesium;
KW   Metal-binding; Nuclease; Plasmid; Transposable element; Transposition.
FT   CHAIN         1    476       Transposase for transposon Tn5.
FT                                /FTId=PRO_0000351545.
FT   REGION        1     70       Interaction with DNA.
FT   REGION      237    255       Interaction with DNA.
FT   REGION      319    348       Interaction with DNA.
FT   REGION      369    476       Important for dimerization.
FT   METAL        97     97       Magnesium 1.
FT   METAL        97     97       Magnesium 2.
FT   METAL       188    188       Magnesium 1.
FT   METAL       326    326       Magnesium 2.
FT   SITE        210    210       Interaction with DNA.
FT   SITE        298    298       Interaction with DNA.
FT   VAR_SEQ       1     55       Missing (in isoform 2). {ECO:0000305}.
FT                                /FTId=VSP_035522.
FT   MUTAGEN      30     30       R->Q: Loss of transposase activity.
FT                                {ECO:0000269|PubMed:11283001}.
FT   MUTAGEN      40     40       K->Q: Strongly reduced transposase
FT                                activity. {ECO:0000269|PubMed:11283001}.
FT   MUTAGEN      41     41       Y->H: Enhances interaction with DNA and
FT                                increases transposition frequency.
FT                                {ECO:0000269|PubMed:9268665}.
FT   MUTAGEN      47     47       T->P: Enhances interaction with DNA and
FT                                increases transposition frequency.
FT                                {ECO:0000269|PubMed:9268665}.
FT   MUTAGEN      54     54       E->K,V: Enhances interaction with DNA and
FT                                increases transposition frequency.
FT                                {ECO:0000269|PubMed:9268665}.
FT   MUTAGEN      56     56       M->A: Abolishes expression of the
FT                                transposase inhibitor Inh (isoform 2).
FT                                {ECO:0000269|PubMed:1310499}.
FT   MUTAGEN      62     62       R->Q: Loss of transposase activity.
FT                                {ECO:0000269|PubMed:11283001}.
FT   MUTAGEN      97     97       D->A: Loss of transposase activity.
FT                                {ECO:0000269|PubMed:11877443}.
FT   MUTAGEN     110    110       E->K: Enhances transposase activity.
FT                                {ECO:0000269|PubMed:1310499}.
FT   MUTAGEN     188    188       D->A: Loss of transposase activity.
FT                                {ECO:0000269|PubMed:11877443}.
FT   MUTAGEN     319    319       Y->A: Loss of strand transfer activity.
FT                                {ECO:0000269|PubMed:11877443}.
FT   MUTAGEN     322    322       R->A,K: Loss of strand transfer activity.
FT                                {ECO:0000269|PubMed:11877443}.
FT   MUTAGEN     322    322       R->Q: Strongly reduced strand transfer
FT                                activity. {ECO:0000269|PubMed:11877443}.
FT   MUTAGEN     326    326       E->A: Loss of transposase activity.
FT                                {ECO:0000269|PubMed:11877443}.
FT   MUTAGEN     330    330       K->A: Reduced transposase activity.
FT                                {ECO:0000269|PubMed:11877443}.
FT   MUTAGEN     330    330       K->R: No effect.
FT                                {ECO:0000269|PubMed:11877443}.
FT   MUTAGEN     333    333       K->A,R: Strongly reduced DNA cleavage.
FT                                Loss of strand transfer activity.
FT                                {ECO:0000269|PubMed:11877443}.
FT   MUTAGEN     342    342       R->A: Abolishes formation of the synaptic
FT                                complex and transposition.
FT                                {ECO:0000269|PubMed:17693501}.
FT   MUTAGEN     344    344       E->A: Enhances transposase activity.
FT                                {ECO:0000269|PubMed:17693501}.
FT   MUTAGEN     345    345       E->K: Enhances transposase activity.
FT                                {ECO:0000269|PubMed:1310499}.
FT   MUTAGEN     348    348       N->A: Reduces formation of synaptic
FT                                complex and transposition.
FT                                {ECO:0000269|PubMed:17693501}.
FT   MUTAGEN     372    372       L->P: Enhances transposase activity.
FT   MUTAGEN     438    438       S->A: Abolishes formation of the synaptic
FT                                complex and transposition.
FT                                {ECO:0000269|PubMed:17693501}.
FT   MUTAGEN     439    439       K->A: Abolishes formation of synaptic
FT                                complex and transposition.
FT                                {ECO:0000269|PubMed:17693501}.
FT   MUTAGEN     445    445       S->A: Reduces formation of synaptic
FT                                complex and transposition.
FT                                {ECO:0000269|PubMed:17693501}.
FT   MUTAGEN     462    462       G->D: Abolishes formation of the synaptic
FT                                complex and transposition.
FT   MUTAGEN     466    466       A->D: Abolishes formation of the synaptic
FT                                complex and transposition.
FT   CONFLICT     64     64       I -> Y (in Ref. 1; AAA73393/AAA73394 and
FT                                2; CAA23891). {ECO:0000305}.
FT   CONFLICT    200    200       K -> R (in Ref. 1; AAA73393/AAA73394 and
FT                                2; CAA23891). {ECO:0000305}.
FT   CONFLICT    225    225       Y -> I (in Ref. 1; AAA73393/AAA73394 and
FT                                2; CAA23891). {ECO:0000305}.
FT   CONFLICT    303    303       S -> G (in Ref. 1; AAA73393/AAA73394 and
FT                                2; CAA23891). {ECO:0000305}.
FT   STRAND        5      8       {ECO:0000244|PDB:3ECP}.
FT   HELIX         9     17       {ECO:0000244|PDB:1MUS}.
FT   STRAND       22     24       {ECO:0000244|PDB:3ECP}.
FT   HELIX        25     40       {ECO:0000244|PDB:1MUS}.
FT   TURN         41     43       {ECO:0000244|PDB:1MUS}.
FT   HELIX        46     49       {ECO:0000244|PDB:1MUS}.
FT   TURN         50     52       {ECO:0000244|PDB:1MUS}.
FT   HELIX        54     64       {ECO:0000244|PDB:1MUS}.
FT   HELIX        71     86       {ECO:0000244|PDB:1MUS}.
FT   STRAND       92    103       {ECO:0000244|PDB:1MUS}.
FT   HELIX       106    110       {ECO:0000244|PDB:1MUS}.
FT   STRAND      114    116       {ECO:0000244|PDB:1MUS}.
FT   STRAND      122    133       {ECO:0000244|PDB:1MUS}.
FT   TURN        134    136       {ECO:0000244|PDB:1MUS}.
FT   STRAND      139    148       {ECO:0000244|PDB:1MUS}.
FT   HELIX       154    156       {ECO:0000244|PDB:1MUS}.
FT   HELIX       161    163       {ECO:0000244|PDB:1MUS}.
FT   HELIX       164    176       {ECO:0000244|PDB:1MUS}.
FT   HELIX       177    182       {ECO:0000244|PDB:1MUS}.
FT   STRAND      183    187       {ECO:0000244|PDB:1MUS}.
FT   HELIX       189    191       {ECO:0000244|PDB:1MUS}.
FT   HELIX       194    202       {ECO:0000244|PDB:1MUS}.
FT   STRAND      206    210       {ECO:0000244|PDB:1MUS}.
FT   TURN        218    220       {ECO:0000244|PDB:1MUS}.
FT   HELIX       224    229       {ECO:0000244|PDB:1MUS}.
FT   STRAND      235    241       {ECO:0000244|PDB:1MUS}.
FT   STRAND      244    247       {ECO:0000244|PDB:1MUS}.
FT   STRAND      253    256       {ECO:0000244|PDB:1MUS}.
FT   STRAND      259    272       {ECO:0000244|PDB:1MUS}.
FT   HELIX       274    276       {ECO:0000244|PDB:1MUS}.
FT   STRAND      277    288       {ECO:0000244|PDB:1MUS}.
FT   STRAND      291    293       {ECO:0000244|PDB:1MUS}.
FT   STRAND      297    304       {ECO:0000244|PDB:1MUS}.
FT   HELIX       309    320       {ECO:0000244|PDB:1MUS}.
FT   HELIX       323    333       {ECO:0000244|PDB:1MUS}.
FT   TURN        334    336       {ECO:0000244|PDB:1MUS}.
FT   HELIX       338    340       {ECO:0000244|PDB:1MUS}.
FT   HELIX       346    370       {ECO:0000244|PDB:1MUS}.
FT   HELIX       382    388       {ECO:0000244|PDB:1B7E}.
FT   HELIX       393    395       {ECO:0000244|PDB:1MUS}.
FT   HELIX       399    409       {ECO:0000244|PDB:1MUS}.
FT   TURN        410    412       {ECO:0000244|PDB:1MUS}.
FT   STRAND      414    416       {ECO:0000244|PDB:1B7E}.
FT   STRAND      419    421       {ECO:0000244|PDB:1MM8}.
FT   HELIX       422    432       {ECO:0000244|PDB:1MUS}.
FT   STRAND      438    440       {ECO:0000244|PDB:1B7E}.
FT   HELIX       446    471       {ECO:0000244|PDB:1MUS}.
SQ   SEQUENCE   476 AA;  53306 MW;  B52F2F143646AF10 CRC64;
     MITSALHRAA DWAKSVFSSA ALGDPRRTAR LVNVAAQLAK YSGKSITISS EGSEAMQEGA
     YRFIRNPNVS AEAIRKAGAM QTVKLAQEFP ELLAIEDTTS LSYRHQVAEE LGKLGSIQDK
     SRGWWVHSVL LLEATTFRTV GLLHQEWWMR PDDPADADEK ESGKWLAAAA TSRLRMGSMM
     SNVIAVCDRE ADIHAYLQDK LAHNERFVVR SKHPRKDVES GLYLYDHLKN QPELGGYQIS
     IPQKGVVDKR GKRKNRPARK ASLSLRSGRI TLKQGNITLN AVLAEEINPP KGETPLKWLL
     LTSEPVESLA QALRVIDIYT HRWRIEEFHK AWKTGAGAER QRMEEPDNLE RMVSILSFVA
     VRLLQLRESF TLPQALRAQG LLKEAEHVES QSAETVLTPD ECQLLGYLDK GKRKRKEKAG
     SLQWAYMAIA RLGGFMDSKR TGIASWGALW EGWEALQSKL DGFLAAKDLM AQGIKI
//
